BiomX Inc.(PHGE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHGE BiomX Inc.

交易中 02-19 14:03:13 EST

5.22

-0.03

-0.57%

最高5.56	最低5.14	成交量3.18万
今开5.36	昨收5.25	日振幅7.99%
总市值796.91万	流通市值538.50万	总股本152.66万
成交额16.95万	换手率3.08%	流通股本103.16万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHGE","market":"US","secType":"STK","nameCN":"BiomX Inc.","latestPrice":5.22,"timestamp":1771527566635,"preClose":5.25,"halted":0,"volume":31754,"delay":0,"changeRate":-0.005714285714285762,"floatShares":1031605,"shares":1526640,"eps":-28.791649,"marketStatus":"交易中","change":-0.03,"latestTime":"02-19 14:03:13 EST","open":5.36,"high":5.5596,"low":5.14,"amount":169471.91090239998,"amplitude":0.079924,"askPrice":5.51,"askSize":100,"bidPrice":5.21,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-28.791649,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771534800000},"marketStatusCode":2,"adr":0,"exchange":"AMEX","adjPreClose":5.25,"preHourTrading":{"tag":"盘前","latestPrice":5.49,"preClose":5.25,"latestTime":"09:29 EST","volume":463,"amount":2472.3101300999997,"timestamp":1771511398440,"change":0.24,"changeRate":0.045714,"amplitude":0.045714},"postHourTrading":{"tag":"盘后","latestPrice":5.35,"preClose":5.25,"latestTime":"19:58 EST","volume":951,"amount":5028.1046,"timestamp":1771462714567,"change":0.1,"changeRate":0.019048,"amplitude":0.019048},"volumeRatio":0.446276},"requestUrl":"/m/hq/s/PHGE/wiki","defaultTab":"wiki","newsList":[{"id":"2607073285","title":"Biomx Inc.盘中异动 股价大跌6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607073285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607073285?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:35","pubTimestamp":1769783719,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日22时35分，Biomx Inc.股票出现异动，股价大幅下挫6.38%。截至发稿，该股报6.60美元/股，成交量3.1921万股，换手率2.09%，振幅9.93%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130223519a6c0aeb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130223519a6c0aeb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2605735444","title":"Biomx Inc.盘中异动 快速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605735444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605735444?lang=zh_cn&edition=full","pubTime":"2026-01-22 23:19","pubTimestamp":1769095150,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日23时19分，Biomx Inc.股票出现波动，股价快速上涨5.23%。截至发稿，该股报3.22美元/股，成交量2.4134万股，换手率1.58%，振幅9.47%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为1.04%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122231910953df11b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122231910953df11b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2605644014","title":"Biomx Inc.盘中异动 急速拉升8.00%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605644014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605644014?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:36","pubTimestamp":1769006160,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日22时36分，Biomx Inc.股票出现波动，股价快速上涨8.00%。截至发稿，该股报2.97美元/股，成交量3801股，换手率0.25%，振幅3.33%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121223600a69cc1b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121223600a69cc1b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"2593495428","title":"Biomx Inc.盘中异动 股价大涨5.02%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593495428","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593495428?lang=zh_cn&edition=full","pubTime":"2025-12-23 23:07","pubTimestamp":1766502426,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日23时07分，Biomx Inc.股票出现波动，股价快速拉升5.02%。截至发稿，该股报2.30美元/股，成交量1.6714万股，换手率1.09%，振幅7.45%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223230707a46f73b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223230707a46f73b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"1110392234","title":"BiomX Inc.收到FDA有关第三方雾化器设备的进一步问询，设备用于Bx004的给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1110392234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110392234?lang=zh_cn&edition=full","pubTime":"2025-11-26 05:42","pubTimestamp":1764106953,"startTime":"0","endTime":"0","summary":"BiomX Inc.收到FDA有关第三方雾化器设备的进一步问询，设备用于Bx004的给药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"1150199749","title":"BiomX Inc.：与设备制造商紧密合作，汇总机构对Bx004的剩余信息要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1150199749","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150199749?lang=zh_cn&edition=full","pubTime":"2025-11-26 05:42","pubTimestamp":1764106951,"startTime":"0","endTime":"0","summary":"BiomX Inc.：与设备制造商紧密合作，汇总机构对Bx004的剩余信息要求","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2586280365","title":"Biomx Inc.盘中异动 早盘急速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586280365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586280365?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:33","pubTimestamp":1764081238,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日22时33分，Biomx Inc.股票出现异动，股价大幅下跌5.20%。截至发稿，该股报5.20美元/股，成交量1620股，换手率0.11%，振幅1.73%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223358977ec8b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125223358977ec8b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2583159639","title":"Biomx Inc.盘中异动 早盘股价大涨5.03%报0.368美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583159639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583159639?lang=zh_cn&edition=full","pubTime":"2025-11-14 23:11","pubTimestamp":1763133108,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日23时11分，Biomx Inc.股票出现波动，股价急速拉升5.03%。截至发稿，该股报0.368美元/股，成交量25.2091万股，换手率0.95%，振幅5.63%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114231148a6f9d533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114231148a6f9d533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"2582347259","title":"Biomx Inc.盘中异动 大幅拉升5.17%报0.411美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582347259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582347259?lang=zh_cn&edition=full","pubTime":"2025-11-12 02:08","pubTimestamp":1762884492,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日02时08分，Biomx Inc.股票出现波动，股价快速上涨5.17%。截至发稿，该股报0.411美元/股，成交量65.1235万股，换手率2.45%，振幅4.68%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为1.56%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120208139762f993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511120208139762f993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"2581729157","title":"Biomx Inc.盘中异动 股价大跌8.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581729157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581729157?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:31","pubTimestamp":1762266666,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时31分，Biomx Inc.股票出现异动，股价大幅跳水8.07%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104223106a6e0b544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104223106a6e0b544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"1127250552","title":"BiomX：预计不再进行额外的非临床研究，FDA对CMC的意见与现有的制造与质量战略一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1127250552","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127250552?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:42","pubTimestamp":1762263733,"startTime":"0","endTime":"0","summary":"BiomX：预计不再进行额外的非临床研究，FDA对CMC的意见与现有的制造与质量战略一致","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"1152750377","title":"BiomX宣布获得FDA积极反馈，支持其用于糖尿病足感染的下一代噬菌体鸡尾酒项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1152750377","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152750377?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:41","pubTimestamp":1762263678,"startTime":"0","endTime":"0","summary":"BiomX宣布获得FDA的积极反馈，支持其针对糖尿病足感染的下一代噬菌体鸡尾酒项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"1187953494","title":"BiomX提供项目更新并宣布新的FDA反馈，可能扩展Bx004的开发路径","url":"https://stock-news.laohu8.com/highlight/detail?id=1187953494","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187953494?lang=zh_cn&edition=full","pubTime":"2025-10-17 20:31","pubTimestamp":1760704270,"startTime":"0","endTime":"0","summary":"BiomX提供项目更新并宣布新的FDA反馈，可能扩展Bx004的开发路径","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2568821213","title":"Biomx Inc.盘中异动 下午盘大幅上涨5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568821213","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568821213?lang=zh_cn&edition=full","pubTime":"2025-09-20 02:31","pubTimestamp":1758306666,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日02时31分，Biomx Inc.股票出现异动，股价急速上涨5.54%。截至发稿，该股报0.537美元/股，成交量24.0766万股，换手率0.91%，振幅5.31%。Biomx Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023106979d9fcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920023106979d9fcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"2565758523","title":"Biomx Inc.盘中异动 早盘股价大跌5.29%报0.503美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565758523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565758523?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:44","pubTimestamp":1756993460,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日21时44分，Biomx Inc.股票出现波动，股价急速下跌5.29%。截至发稿，该股报0.503美元/股，成交量4.3533万股，换手率0.16%，振幅1.83%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Biomx Inc.公司简介：BiomX Inc 专注于开发天然和工程噬菌体混合物以及个性化疗法，为了在靶向和消灭慢性疾病中的有害细菌，包括囊性纤维化和糖尿病足骨髓炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904214420a4b414bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904214420a4b414bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2518746562","title":"Biomx Inc.盘中异动 临近午盘急速下跌6.51%报0.560美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518746562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518746562?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:42","pubTimestamp":1741621321,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时42分，Biomx Inc.股票出现波动，股价大幅跳水6.51%。截至发稿，该股报0.560美元/股，成交量2.6663万股，换手率0.11%，振幅3.36%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3631.78%、2214.09%、815.81%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scisparc Ltd.、Dogwood Therapeutics, Inc.，振幅分别为78.32%、49.87%、41.36%。Biomx Inc.公司简介：BiomX Inc是一家总部位于以色列的临床阶段微生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310234201964052ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310234201964052ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2516670716","title":"Biomx Inc.盘中异动 早盘快速下挫5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670716?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:58","pubTimestamp":1741100282,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时58分，Biomx Inc.股票出现异动，股价快速跳水5.79%。截至发稿，该股报0.630美元/股，成交量2362股，换手率0.01%，振幅0.00%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Biomx Inc.公司简介：BiomX Inc是一家总部位于以色列的临床阶段微生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225802abe7f7f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225802abe7f7f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHGE","BK4139"],"gpt_icon":0},{"id":"2516340626","title":"Biomx Inc.盘中异动 快速拉升7.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516340626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516340626?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012352,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Biomx Inc.股票出现异动，股价快速上涨7.42%。截至发稿，该股报0.671美元/股，成交量2.2166万股，换手率0.12%，振幅0.00%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.42%、27.52%、22.99%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Cibus, Inc.，振幅分别为21.22%、19.25%、9.55%。Biomx Inc.公司简介：BiomX Inc是一家总部位于以色列的临床阶段微生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032232329637ac53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032232329637ac53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"2516844379","title":"Biomx Inc.盘中异动 早盘快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516844379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516844379?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:53","pubTimestamp":1740757982,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时53分，Biomx Inc.股票出现异动，股价急速跳水5.03%。截至发稿，该股报0.646美元/股，成交量2.5091万股，换手率0.14%，振幅4.96%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Biomx Inc.公司简介：BiomX Inc是一家总部位于以色列的临床阶段微生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823530296342c02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823530296342c02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0},{"id":"2514783386","title":"Biomx Inc.盘中异动 早盘快速跳水5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514783386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514783386?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:56","pubTimestamp":1740668163,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时56分，Biomx Inc.股票出现异动，股价急速下挫5.55%。截至发稿，该股报0.756美元/股，成交量8265股，换手率0.05%，振幅0.00%。Biomx Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Biomx Inc.公司简介：BiomX Inc是一家总部位于以色列的临床阶段微生物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225603a256801f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225603a256801f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHGE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomx.com","stockEarnings":[{"period":"1week","weight":-0.0675},{"period":"1month","weight":0.959},{"period":"3month","weight":0.0048},{"period":"6month","weight":-0.4947},{"period":"1year","weight":-0.7029},{"period":"ytd","weight":1.8075}],"compareEarnings":[{"period":"1week","weight":-0.0082},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1223},{"period":"ytd","weight":0.0064}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BiomX Inc.于2017年11月1日根据特拉华州法律成立。2019年10月28日，该公司与BiomX Ltd.合并，然后更名为BiomX Inc.。该公司正在开发天然和工程化的噬菌体混合物，旨在针对和消灭慢性疾病中的有害细菌，目前主要致力于囊性纤维化，并在较小程度上致力于特应性皮炎。该公司发现并验证专有细菌靶点，并针对这些靶点定制噬菌体组合物。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.415936},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.028572},{"month":3,"riseRate":0.333333,"avgChangeRate":0.132083},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.052316},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.104594},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.042142},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.028521},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.072801},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.126957},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.11497},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.17671},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.097259}],"exchange":"AMEX","name":"BiomX Inc.","nameEN":"BiomX Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BiomX Inc.(PHGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BiomX Inc.(PHGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BiomX Inc.,PHGE,BiomX Inc.股票,BiomX Inc.股票老虎,BiomX Inc.股票老虎国际,BiomX Inc.行情,BiomX Inc.股票行情,BiomX Inc.股价,BiomX Inc.股市,BiomX Inc.股票价格,BiomX Inc.股票交易,BiomX Inc.股票购买,BiomX Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BiomX Inc.(PHGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BiomX Inc.(PHGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}